Brief: Avenira Says Additional Investment From Sichuan Hebang Biotechnology
27/02/2026 01:38
Feb 27 (Reuters) - Avenira Ltd AEV.AX: ADDITIONAL INVESTMENT FROM SICHUAN HEBANG BIOTECHNOLOGY INVESTMENT COMPRISES PLACEMENT OF A$8.8 MILLION AT ISSUE PRICE OF A$0.0075 PER NEW SHARE Further company coverage: AEV.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Avenira
See all newsAustralia's Avenira jumps most in more than 6 years on project development financing
Brief: Avenira Enters Facility Arrangements With Hebang For Up To A$85 Million
Australia's Avenira falls on discounted capital raising
Brief: Avenira Announces Renounceable Rights Issue
Brief: Avenira Formally Approved A$2.6M Exploration Budget To Advance Jundee South Gold Project